Report Detail
Global Disease Control and Prevention Vaccine Market Insights and Forecast to 2026
- RnM4114753 |
- 05 August, 2020 |
- Global |
- 115 Pages |
- QYResearch |
- Pharma & Healthcare
Disease Control and Prevention Vaccine market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Disease Control and Prevention Vaccine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Disease Control and Prevention Vaccine market is segmented into
Live-Attenuated
Inactivated
Recombinant Sub Unit and Toxoid
Segment by Application, the Disease Control and Prevention Vaccine market is segmented into
Pediatric Vaccine
Adult Vaccine
Regional and Country-level Analysis
The Disease Control and Prevention Vaccine market is analysed and market size information is provided by regions (countries).
The key regions covered in the Disease Control and Prevention Vaccine market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Disease Control and Prevention Vaccine Market Share Analysis
Disease Control and Prevention Vaccine market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Disease Control and Prevention Vaccine business, the date to enter into the Disease Control and Prevention Vaccine market, Disease Control and Prevention Vaccine product introduction, recent developments, etc.
The major vendors covered:
GSK
Merck & Co., Inc
Pfizer
Sanofi
AstraZeneca PLC
Sinovac Biotech Ltd
Astellas Pharma Inc
Serum Institute of India Pvt. Ltd
Daiichi Sankyo
1 Study Coverage
- 1.1 Disease Control and Prevention Vaccine Product Introduction
- 1.2 Market Segments
- 1.3 Key Disease Control and Prevention Vaccine Manufacturers Covered: Ranking by Revenue
- 1.4 Market by Type
- 1.4.1 Global Disease Control and Prevention Vaccine Market Size Growth Rate by Type
- 1.4.2 Live-Attenuated
- 1.4.3 Inactivated
- 1.4.4 Recombinant Sub Unit and Toxoid
- 1.5 Market by Application
- 1.5.1 Global Disease Control and Prevention Vaccine Market Size Growth Rate by Application
- 1.5.2 Pediatric Vaccine
- 1.5.3 Adult Vaccine
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Disease Control and Prevention Vaccine Market Size, Estimates and Forecasts
- 2.1.1 Global Disease Control and Prevention Vaccine Revenue 2015-2026
- 2.1.2 Global Disease Control and Prevention Vaccine Sales 2015-2026
- 2.2 Global Disease Control and Prevention Vaccine, Market Size by Producing Regions: 2015 VS 2020 VS 2026
- 2.2.1 Global Disease Control and Prevention Vaccine Retrospective Market Scenario in Sales by Region: 2015-2020
- 2.2.2 Global Disease Control and Prevention Vaccine Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Disease Control and Prevention Vaccine Competitor Landscape by Players
- 3.1 Disease Control and Prevention Vaccine Sales by Manufacturers
- 3.1.1 Disease Control and Prevention Vaccine Sales by Manufacturers (2015-2020)
- 3.1.2 Disease Control and Prevention Vaccine Sales Market Share by Manufacturers (2015-2020)
- 3.2 Disease Control and Prevention Vaccine Revenue by Manufacturers
- 3.2.1 Disease Control and Prevention Vaccine Revenue by Manufacturers (2015-2020)
- 3.2.2 Disease Control and Prevention Vaccine Revenue Share by Manufacturers (2015-2020)
- 3.2.3 Global Disease Control and Prevention Vaccine Market Concentration Ratio (CR5 and HHI) (2015-2020)
- 3.2.4 Global Top 10 and Top 5 Companies by Disease Control and Prevention Vaccine Revenue in 2019
- 3.2.5 Global Disease Control and Prevention Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
- 3.3 Disease Control and Prevention Vaccine Price by Manufacturers
- 3.4 Disease Control and Prevention Vaccine Manufacturing Base Distribution, Product Types
- 3.4.1 Disease Control and Prevention Vaccine Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Disease Control and Prevention Vaccine Product Type
- 3.4.3 Date of International Manufacturers Enter into Disease Control and Prevention Vaccine Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
- 4.1 Global Disease Control and Prevention Vaccine Market Size by Type (2015-2020)
- 4.1.1 Global Disease Control and Prevention Vaccine Sales by Type (2015-2020)
- 4.1.2 Global Disease Control and Prevention Vaccine Revenue by Type (2015-2020)
- 4.1.3 Disease Control and Prevention Vaccine Average Selling Price (ASP) by Type (2015-2026)
- 4.2 Global Disease Control and Prevention Vaccine Market Size Forecast by Type (2021-2026)
- 4.2.1 Global Disease Control and Prevention Vaccine Sales Forecast by Type (2021-2026)
- 4.2.2 Global Disease Control and Prevention Vaccine Revenue Forecast by Type (2021-2026)
- 4.2.3 Disease Control and Prevention Vaccine Average Selling Price (ASP) Forecast by Type (2021-2026)
- 4.3 Global Disease Control and Prevention Vaccine Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
- 5.1 Global Disease Control and Prevention Vaccine Market Size by Application (2015-2020)
- 5.1.1 Global Disease Control and Prevention Vaccine Sales by Application (2015-2020)
- 5.1.2 Global Disease Control and Prevention Vaccine Revenue by Application (2015-2020)
- 5.1.3 Disease Control and Prevention Vaccine Price by Application (2015-2020)
- 5.2 Disease Control and Prevention Vaccine Market Size Forecast by Application (2021-2026)
- 5.2.1 Global Disease Control and Prevention Vaccine Sales Forecast by Application (2021-2026)
- 5.2.2 Global Disease Control and Prevention Vaccine Revenue Forecast by Application (2021-2026)
- 5.2.3 Global Disease Control and Prevention Vaccine Price Forecast by Application (2021-2026)
6 North America
- 6.1 North America Disease Control and Prevention Vaccine by Country
- 6.1.1 North America Disease Control and Prevention Vaccine Sales by Country
- 6.1.2 North America Disease Control and Prevention Vaccine Revenue by Country
- 6.1.3 U.S.
- 6.1.4 Canada
- 6.2 North America Disease Control and Prevention Vaccine Market Facts & Figures by Type
- 6.3 North America Disease Control and Prevention Vaccine Market Facts & Figures by Application
7 Europe
- 7.1 Europe Disease Control and Prevention Vaccine by Country
- 7.1.1 Europe Disease Control and Prevention Vaccine Sales by Country
- 7.1.2 Europe Disease Control and Prevention Vaccine Revenue by Country
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 U.K.
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Disease Control and Prevention Vaccine Market Facts & Figures by Type
- 7.3 Europe Disease Control and Prevention Vaccine Market Facts & Figures by Application
8 Asia Pacific
- 8.1 Asia Pacific Disease Control and Prevention Vaccine by Region
- 8.1.1 Asia Pacific Disease Control and Prevention Vaccine Sales by Region
- 8.1.2 Asia Pacific Disease Control and Prevention Vaccine Revenue by Region
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 South Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Taiwan
- 8.1.9 Indonesia
- 8.1.10 Thailand
- 8.1.11 Malaysia
- 8.1.12 Philippines
- 8.1.13 Vietnam
- 8.2 Asia Pacific Disease Control and Prevention Vaccine Market Facts & Figures by Type
- 8.3 Asia Pacific Disease Control and Prevention Vaccine Market Facts & Figures by Application
9 Latin America
- 9.1 Latin America Disease Control and Prevention Vaccine by Country
- 9.1.1 Latin America Disease Control and Prevention Vaccine Sales by Country
- 9.1.2 Latin America Disease Control and Prevention Vaccine Revenue by Country
- 9.1.3 Mexico
- 9.1.4 Brazil
- 9.1.5 Argentina
- 9.2 Central & South America Disease Control and Prevention Vaccine Market Facts & Figures by Type
- 9.3 Central & South America Disease Control and Prevention Vaccine Market Facts & Figures by Application
10 Middle East and Africa
- 10.1 Middle East and Africa Disease Control and Prevention Vaccine by Country
- 10.1.1 Middle East and Africa Disease Control and Prevention Vaccine Sales by Country
- 10.1.2 Middle East and Africa Disease Control and Prevention Vaccine Revenue by Country
- 10.1.3 Turkey
- 10.1.4 Saudi Arabia
- 10.1.5 U.A.E
- 10.2 Middle East and Africa Disease Control and Prevention Vaccine Market Facts & Figures by Type
- 10.3 Middle East and Africa Disease Control and Prevention Vaccine Market Facts & Figures by Application
11 Company Profiles
- 11.1 GSK
- 11.1.1 GSK Corporation Information
- 11.1.2 GSK Description and Business Overview
- 11.1.3 GSK Sales, Revenue and Gross Margin (2015-2020)
- 11.1.4 GSK Disease Control and Prevention Vaccine Products Offered
- 11.1.5 GSK Related Developments
- 11.2 Merck & Co., Inc
- 11.2.1 Merck & Co., Inc Corporation Information
- 11.2.2 Merck & Co., Inc Description and Business Overview
- 11.2.3 Merck & Co., Inc Sales, Revenue and Gross Margin (2015-2020)
- 11.2.4 Merck & Co., Inc Disease Control and Prevention Vaccine Products Offered
- 11.2.5 Merck & Co., Inc Related Developments
- 11.3 Pfizer
- 11.3.1 Pfizer Corporation Information
- 11.3.2 Pfizer Description and Business Overview
- 11.3.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
- 11.3.4 Pfizer Disease Control and Prevention Vaccine Products Offered
- 11.3.5 Pfizer Related Developments
- 11.4 Sanofi
- 11.4.1 Sanofi Corporation Information
- 11.4.2 Sanofi Description and Business Overview
- 11.4.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
- 11.4.4 Sanofi Disease Control and Prevention Vaccine Products Offered
- 11.4.5 Sanofi Related Developments
- 11.5 AstraZeneca PLC
- 11.5.1 AstraZeneca PLC Corporation Information
- 11.5.2 AstraZeneca PLC Description and Business Overview
- 11.5.3 AstraZeneca PLC Sales, Revenue and Gross Margin (2015-2020)
- 11.5.4 AstraZeneca PLC Disease Control and Prevention Vaccine Products Offered
- 11.5.5 AstraZeneca PLC Related Developments
- 11.6 Sinovac Biotech Ltd
- 11.6.1 Sinovac Biotech Ltd Corporation Information
- 11.6.2 Sinovac Biotech Ltd Description and Business Overview
- 11.6.3 Sinovac Biotech Ltd Sales, Revenue and Gross Margin (2015-2020)
- 11.6.4 Sinovac Biotech Ltd Disease Control and Prevention Vaccine Products Offered
- 11.6.5 Sinovac Biotech Ltd Related Developments
- 11.7 Astellas Pharma Inc
- 11.7.1 Astellas Pharma Inc Corporation Information
- 11.7.2 Astellas Pharma Inc Description and Business Overview
- 11.7.3 Astellas Pharma Inc Sales, Revenue and Gross Margin (2015-2020)
- 11.7.4 Astellas Pharma Inc Disease Control and Prevention Vaccine Products Offered
- 11.7.5 Astellas Pharma Inc Related Developments
- 11.8 Serum Institute of India Pvt. Ltd
- 11.8.1 Serum Institute of India Pvt. Ltd Corporation Information
- 11.8.2 Serum Institute of India Pvt. Ltd Description and Business Overview
- 11.8.3 Serum Institute of India Pvt. Ltd Sales, Revenue and Gross Margin (2015-2020)
- 11.8.4 Serum Institute of India Pvt. Ltd Disease Control and Prevention Vaccine Products Offered
- 11.8.5 Serum Institute of India Pvt. Ltd Related Developments
- 11.9 Daiichi Sankyo
- 11.9.1 Daiichi Sankyo Corporation Information
- 11.9.2 Daiichi Sankyo Description and Business Overview
- 11.9.3 Daiichi Sankyo Sales, Revenue and Gross Margin (2015-2020)
- 11.9.4 Daiichi Sankyo Disease Control and Prevention Vaccine Products Offered
- 11.9.5 Daiichi Sankyo Related Developments
- 11.1 GSK
- 11.1.1 GSK Corporation Information
- 11.1.2 GSK Description and Business Overview
- 11.1.3 GSK Sales, Revenue and Gross Margin (2015-2020)
- 11.1.4 GSK Disease Control and Prevention Vaccine Products Offered
- 11.1.5 GSK Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
- 12.1 Disease Control and Prevention Vaccine Market Estimates and Projections by Region
- 12.1.1 Global Disease Control and Prevention Vaccine Sales Forecast by Regions 2021-2026
- 12.1.2 Global Disease Control and Prevention Vaccine Revenue Forecast by Regions 2021-2026
- 12.2 North America Disease Control and Prevention Vaccine Market Size Forecast (2021-2026)
- 12.2.1 North America: Disease Control and Prevention Vaccine Sales Forecast (2021-2026)
- 12.2.2 North America: Disease Control and Prevention Vaccine Revenue Forecast (2021-2026)
- 12.2.3 North America: Disease Control and Prevention Vaccine Market Size Forecast by Country (2021-2026)
- 12.3 Europe Disease Control and Prevention Vaccine Market Size Forecast (2021-2026)
- 12.3.1 Europe: Disease Control and Prevention Vaccine Sales Forecast (2021-2026)
- 12.3.2 Europe: Disease Control and Prevention Vaccine Revenue Forecast (2021-2026)
- 12.3.3 Europe: Disease Control and Prevention Vaccine Market Size Forecast by Country (2021-2026)
- 12.4 Asia Pacific Disease Control and Prevention Vaccine Market Size Forecast (2021-2026)
- 12.4.1 Asia Pacific: Disease Control and Prevention Vaccine Sales Forecast (2021-2026)
- 12.4.2 Asia Pacific: Disease Control and Prevention Vaccine Revenue Forecast (2021-2026)
- 12.4.3 Asia Pacific: Disease Control and Prevention Vaccine Market Size Forecast by Region (2021-2026)
- 12.5 Latin America Disease Control and Prevention Vaccine Market Size Forecast (2021-2026)
- 12.5.1 Latin America: Disease Control and Prevention Vaccine Sales Forecast (2021-2026)
- 12.5.2 Latin America: Disease Control and Prevention Vaccine Revenue Forecast (2021-2026)
- 12.5.3 Latin America: Disease Control and Prevention Vaccine Market Size Forecast by Country (2021-2026)
- 12.6 Middle East and Africa Disease Control and Prevention Vaccine Market Size Forecast (2021-2026)
- 12.6.1 Middle East and Africa: Disease Control and Prevention Vaccine Sales Forecast (2021-2026)
- 12.6.2 Middle East and Africa: Disease Control and Prevention Vaccine Revenue Forecast (2021-2026)
- 12.6.3 Middle East and Africa: Disease Control and Prevention Vaccine Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Porter's Five Forces Analysis
- 13.5 Primary Interviews with Key Disease Control and Prevention Vaccine Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Disease Control and Prevention Vaccine Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Disease Control and Prevention Vaccine. Industry analysis & Market Report on Disease Control and Prevention Vaccine is a syndicated market report, published as Global Disease Control and Prevention Vaccine Market Insights and Forecast to 2026. It is complete Research Study and Industry Analysis of Disease Control and Prevention Vaccine market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
